Transfer details. The company has transferred the shares to Shenhai Securities.
The application was submitted, and the company's stock (stock abbreviation: Kechuang Bio, stock code: ******) was issued on January 31, 2024.
Trading will be suspended from the opening of the market on Wednesday morning...
The suspension of trading in Kechuang Bio and the subsequent private transfer of non-tradable restricted shares by its major shareholder have caused a huge uproar in the investment community.
With the steady rise in the stock price of Kechuang Bio, especially given the enthusiastic response after the launch of its brain-computer interface VR product, Zheng Li had no reason to transfer the company.
"Will this tech-driven biotech company go bankrupt?"
"You're overthinking it. With a company this expensive, how could the transferee not conduct due diligence when transferring shares?"
"It's possible that Zheng Shen simply wants to cash out some of his shares. Since non-tradable shares are not easy to trade on the market, this is the only way he can do it."
"As long as Zheng Shen remains the chairman of Kechuang Biotechnology, I will continue to hold shares in Kechuang Biotechnology."
"Let's wait and see the annual report. The transferee hasn't been announced yet, and it's possible that the transferee might be able to help the development of Kechuang Bio in some aspects."
The stock forum of Kechuang Bio is very lively. As the company with the highest market value among listed companies in China, Kechuang Bio's stock forum has always been very active.
The sudden announcement only made things more lively here.
While individual investors were still speculating, investment institutions had already received the news.
With such a large scale and such high capital flow, it's clear that top investment institutions can't hide it from them.
"I really didn't expect Zheng Li to transfer shares at this time. Not everyone has the courage to sell shares during the rising period."
“Zheng Li is no ordinary person. I just regret that we are not the transferee. Kechuang Bio is such a good company, and we only have five percent of the shares.”
"There's nothing we can do. The transferee is a Chinese investor. What can we use to compete with them in China?"
Huaguo Investment Co., Ltd. had a registered capital of 200 billion US dollars when it was established in 2007.
One of the world's largest sovereign wealth funds, known for its vast wealth.
(The chairman of my former employer later became the chairman of Huaguo Investment Group.)
"We can only regret that we didn't expect Zheng Li to be willing to sell his shares at this time. If we had talked to Zheng Li in advance, we might have had a chance."
"Have you considered that Huaguo Investment Co., Ltd. has offered a bargaining chip that we cannot offer?"
“For this level of transaction, money is secondary. It’s possible that we can’t offer the resources we need. This makes Kechuang Bio’s position even more secure.”
"And if you regret that we weren't the transferee this time, then we wouldn't have been able to seize this opportunity."
Perhaps we should regret that when we received our Series B funding for Kechuang Bio, we only got 5% of the shares.
"If only we had acquired 10% of the shares back then."
Li Shuyao was also indirectly affected; after getting off work at 10 p.m., she made a phone call to Li Miaomiao:
"Miaomiao, this is too difficult. Why did Zheng Li suddenly transfer his shares?"
After turning on the speakerphone, Li Miaomiao said while washing up, "The company needs to develop, so the shares are being transferred."
Li Shuyao asked, "Do you know who the transferee is?"
"My supervisor asked me to write a research report on the share transfer by the controlling shareholder of Kechuang Biotechnology, and it needs to be unique."
"The problem is that there are so many research reports on innovative biotechnology, how do we write something unique?"
"Currently, there is only one announcement, and we know nothing about the transferee, the share transfer amount, or the price."
"Writing a research report with originality under these circumstances is truly a challenge for me."
"Sometimes, you might wonder if your boss lives in outer space and is completely out of touch with reality when they make certain demands of you."
After Li Shuyao finished complaining, Li Miaomiao slowly said:
"The transferee is also a state-owned enterprise with 'China' in its name. I guess your leaders must have received the news. This is a test for you."
Li Shuyao suddenly realized: "A state-owned enterprise? Could it be China Financial Holding?"
"It shouldn't be. If it were CICC, with such a positive development, the experts who got the news should have already pushed CICC up with a large volume bullish candle."
Li Miaomiao ran her mind through the list but couldn't come up with anything. There were too many state-owned enterprises, and quite a few of them were quite powerful.
She couldn't really guess which one it was: "It shouldn't be a listed state-owned enterprise; it should be a wholly state-owned enterprise."
"No wonder, now I know how to write a research report."
"Let's start with the diversification of shareholders and the positive expectations of the Chinese government for the future development of Kechuang Bio."
"Write about further enhancing the strategic importance of science and technology innovation in biotechnology."
Just give it any name, and then you can easily change it with one click when the official announcement comes out.
Most importantly, research reports must be released as soon as possible, and they must be factual. Brokerage research reports have become incredibly competitive in recent years.
If it weren't so volatile, there wouldn't be securities analysts using the Five Elements theory to interpret the A-shares market.
However, the "big A" is indeed a mysterious phenomenon.
Li Miaomiao laughed and said, "Haha, the way you write research reports so skillfully makes my heart ache."
Li Shuyao smiled wryly: "This is what it's like to be a miserable investment banker. Writing and reading research reports are just basic skills."
Experienced investment bankers know exactly how much fluff a research report contains, which parts are copied and pasted, and which brokerage reports actually contain valuable information.
Li Shuyao asked, "You came back from Singapore a few days ago? Did you and Zheng Li spend a few days alone together?"
Li Miaomiao was already used to Li Shuyao's teasing: "For work-related matters, Zheng Li's signature and fingerprint are required."
As if remembering something, Li Shuyao asked, "Has Zheng Shen considered how to manage the money from this share transfer?"
This chapter is not finished, please click the next page to continue reading!
Continue read on readnovelmtl.com
